Latest Period
Q4 2025
Security Snapshot
FILANA THERAPEUTICS, INC. - Common Stock (FLNA) Institutional Ownership
CUSIP: 14817C107
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
104
Shares (Excl. Options)
13,806,553
Price
$1.98
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- FLNA on Nasdaq
- Shares outstanding
- 48,331,225
- Price per share
- $1.67
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 13,806,553
- Total reported value
- $27,335,635
- % of total 13F portfolios
- 0%
- Share change
- +185,871
- Value change
- -$753,360
- Number of holders
- 104
- Price from insider filings
- $1.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- FLNA - FILANA THERAPEUTICS, INC. - Common Stock is tracked under CUSIP 14817C107.
- 104 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 104 to 31 between Q4 2025 and Q1 2026.
- Reported value moved from $27,335,635 to $5,165,271.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 104 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 14817C107?
CUSIP 14817C107 identifies FLNA - FILANA THERAPEUTICS, INC. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14817C107:
Significant Owners of FILANA THERAPEUTICS, INC. - Common Stock (FLNA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nachtrab Matthew | 4.7% | $3,560,189 | 2,267,636 | Nachtrab Matthew | 16 Aug 2024 | |||
| VANGUARD GROUP INC | 4.5% | $3,927,830 | 2,170,072 | The Vanguard Group | 30 Jun 2025 | |||
| BlackRock, Inc. | 3.2% | $2,797,129 | 1,545,375 | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Dec 2025, 104 institutional investors reported holding 13,806,553 shares of FILANA THERAPEUTICS, INC. - Common Stock (FLNA). This represents 29% of the company’s total 48,331,225 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of FILANA THERAPEUTICS, INC. - Common Stock (FLNA) together control 26% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.9% | 2,375,589 | +3.8% | 0% | $4,703,666 |
| MARSHALL WACE, LLP | 4.4% | 2,115,307 | +2.6% | 0% | $4,188,307 |
| BlackRock, Inc. | 2.9% | 1,419,934 | +0.76% | 0% | $2,811,469 |
| TWO SIGMA ADVISERS, LP | 2% | 954,800 | -0.7% | 0% | $1,890,504 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 642,401 | +14% | 0% | $1,271,954 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 545,969 | +1.5% | 0% | $1,081,433 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.1% | 528,018 | +38% | 0% | $1,045,476 |
| JANE STREET GROUP, LLC | 1.1% | 513,137 | +162% | 0% | $1,016,011 |
| D. E. Shaw & Co., Inc. | 0.97% | 469,326 | 0% | $929,266 | |
| Point72 Asset Management, L.P. | 0.62% | 299,579 | 0% | $593,166 | |
| GSA CAPITAL PARTNERS LLP | 0.6% | 287,879 | 0.05% | $570,000 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.59% | 284,213 | +1063% | 0% | $561,000 |
| MILLENNIUM MANAGEMENT LLC | 0.57% | 274,399 | -14% | 0% | $543,310 |
| GROUP ONE TRADING LLC | 0.56% | 269,470 | +34% | 0.02% | $533,551 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.51% | 246,987 | +9.9% | 0% | $489,034 |
| STATE STREET CORP | 0.44% | 212,187 | -0.4% | 0% | $420,130 |
| Susquehanna Portfolio Strategies, LLC | 0.43% | 206,835 | 0% | 0.01% | $409,533 |
| SIMPLEX TRADING, LLC | 0.36% | 173,065 | +7% | 0.01% | $342,668 |
| NORTHERN TRUST CORP | 0.31% | 149,194 | +14% | 0% | $295,405 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.3% | 144,100 | 0% | $285,318 | |
| DIMENSIONAL FUND ADVISORS LP | 0.29% | 140,057 | 0% | $277,313 | |
| Graham Capital Management, L.P. | 0.27% | 128,703 | +9.1% | 0.01% | $254,832 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.21% | 100,577 | 0% | $199,142 | |
| Jump Financial, LLC | 0.19% | 91,620 | 0% | $181,408 | |
| FEDERATED HERMES, INC. | 0.19% | 91,479 | +111% | 0% | $181,128 |
Institutional Holders of FILANA THERAPEUTICS, INC. - Common Stock (FLNA) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,056,780 | $5,165,271 | -$56,820 | $1.69 | 31 |
| 2025 Q4 | 13,806,553 | $27,335,635 | -$753,360 | $1.98 | 104 |
| 2025 Q3 | 13,778,326 | $40,074,441 | +$5,040,034 | $2.91 | 101 |
| 2025 Q2 | 12,246,863 | $22,166,624 | -$6,209,960 | $1.81 | 96 |
| 2025 Q1 | 15,768,881 | $23,653,533 | -$3,650,996 | $1.50 | 114 |
| 2024 Q4 | 17,411,806 | $41,096,950 | -$26,811,358 | $2.36 | 135 |
| 2024 Q3 | 14,006,298 | $412,343,524 | +$21,408,686 | $29.43 | 159 |
| 2024 Q2 | 13,297,542 | $164,180,761 | +$20,340,671 | $12.35 | 140 |
| 2024 Q1 | 11,593,879 | $235,338,414 | -$49,008,344 | $20.29 | 141 |
| 2023 Q4 | 13,929,974 | $313,474,831 | +$20,318,834 | $22.51 | 150 |
| 2023 Q3 | 12,909,705 | $214,797,641 | +$17,325,070 | $16.64 | 136 |
| 2023 Q2 | 11,697,131 | $286,735,353 | -$6,324,947 | $24.52 | 150 |
| 2023 Q1 | 11,914,630 | $287,373,528 | +$15,058,161 | $24.12 | 140 |
| 2022 Q4 | 11,254,249 | $332,457,243 | +$2,217,261 | $29.54 | 146 |
| 2022 Q3 | 10,511,058 | $439,522,416 | +$28,422,554 | $41.82 | 164 |
| 2022 Q2 | 9,860,019 | $277,264,167 | -$22,312,348 | $28.12 | 136 |
| 2022 Q1 | 10,487,576 | $389,768,314 | -$39,764,775 | $37.14 | 147 |
| 2021 Q4 | 11,534,283 | $504,052,860 | -$49,487,683 | $43.70 | 160 |
| 2021 Q3 | 12,113,852 | $751,991,955 | +$67,636,793 | $62.08 | 169 |
| 2021 Q2 | 10,434,065 | $891,498,117 | +$48,315,268 | $85.44 | 163 |
| 2021 Q1 | 10,158,803 | $456,594,941 | +$91,884,258 | $44.95 | 116 |
| 2020 Q4 | 9,404,804 | $64,135,775 | +$15,501,397 | $6.82 | 70 |
| 2020 Q3 | 6,699,572 | $77,113,513 | +$9,133,318 | $11.51 | 63 |
| 2020 Q2 | 5,994,033 | $18,463,673 | -$2,167,955 | $3.08 | 47 |
| 2020 Q1 | 6,007,016 | $24,760,000 | +$5,851,160 | $4.11 | 38 |
| 2019 Q4 | 4,360,623 | $22,674,000 | +$6,170,969 | $5.20 | 27 |
| 2019 Q3 | 1,823,694 | $2,188,000 | -$1,850,994 | $1.20 | 16 |
| 2019 Q2 | 3,351,011 | $4,055,000 | +$2,993 | $1.21 | 20 |
| 2019 Q1 | 3,342,185 | $4,312,000 | +$4,312,000 | $1.29 | 22 |